Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot Q13261 (I15RA_HUMAN)

Last modified November 25, 2008. Version 71. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Interleukin-15 receptor subunit alpha
      Short name=IL-15R-alpha
      Short name=IL-15RA
Cleaved into the following chain:
    1- Recommended name:
            Soluble interleukin-15 receptor subunit alpha
                Short name=sIL-15R-alpha
                Short name=sIL-15RA
Gene names
Name: IL15RA
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length267 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Receptor for interleukin-15. Expression of different isoforms may alter or interfere with signal transduction. Isoform 6, isoform 7, isoform 8 and isoform 9 do not bind IL15. Signal transduction involves STAT3, STAT5, STAT6, JAK2 By similarity and SYK.

Subunit structure

The interleukin-15 receptor IL15R is a heterotrimer of IL15RA, IL2RB and IL2RG. IL15RA also self-associates By similarity. Interacts with SYK.

Subcellular location

Membrane; Single-pass type I membrane protein. Nucleus membrane; Single-pass type I membrane protein. Note= Mainly found associated with the nuclear membrane.

Isoform 6: Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Cytoplasmic vesicle membrane; Single-pass type I membrane protein. Membrane; Single-pass type I membrane protein. Note= Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.

Isoform 7: Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Cytoplasmic vesicle membrane; Single-pass type I membrane protein. Membrane; Single-pass type I membrane protein. Note= Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.

Isoform 8: Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Cytoplasmic vesicle membrane; Single-pass type I membrane protein. Membrane; Single-pass type I membrane protein. Note= Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.

Isoform 9: Endoplasmic reticulum membrane; Single-pass type I membrane protein. Golgi apparatus membrane; Single-pass type I membrane protein. Cytoplasmic vesicle membrane; Single-pass type I membrane protein. Membrane; Single-pass type I membrane protein. Note= Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.

Soluble interleukin-15 receptor subunit alpha: Secretedextracellular space.

Tissue specificity

Isoform 1, isoform 3, isoform 4, isoform 5, isoform 6, isoform 7, isoform 8 and isoform 9 are widely expressed. Expressed in fetal brain with higher expression in the hippocampus and cerebellum than in cortex and thalamus. Higher levels of soluble sIL-15RA form in comparison with membrane-bound forms is present in all brain structures.

Post-translational modification

A soluble form (sIL-15RA) arises from proteolytic shedding of the membrane-anchored receptor. The cleavage involves ADAM17/TACE By similarity. It also binds IL-15 and thus interferes with IL-15 binding to the membrane receptor.

Phosphorylated by activated SYK.

N-glycosylated and O-glycosylated.

Sequence similarities

Contains 1 Sushi (CCP/SCR) domain.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

IL15P409331EBI-980354,EBI-980274

Alternative products

This entry describes 9 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q13261-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q13261-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-36: Missing.
Isoform 3 (identifier: Q13261-3)

Also known as: delta3E1E7Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     95-128: RDPALVHQRPAPPSTVTTAGVTPQPESLSPSGKE → K
Isoform 4 (identifier: Q13261-4)

Also known as: E1E7'Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     232-267: QTPPLASVEMEAMEALPVTWGTSSRDEDLENCSHHL → ASVCSCHPRSAGHTCSVGSV
Isoform 5 (identifier: Q13261-5)

Also known as: delta3E1E7'Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     95-128: RDPALVHQRPAPPSTVTTAGVTPQPESLSPSGKE → K
     232-267: QTPPLASVEMEAMEALPVTWGTSSRDEDLENCSHHL → ASVCSCHPRSAGHTCSVGSV
Isoform 6 (identifier: Q13261-6)

Also known as: delta2E1E7Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     31-95: Missing.
Notes: Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.
Isoform 7 (identifier: Q13261-7)

Also known as: delta2E1E7'Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     31-95: Missing.
     232-267: QTPPLASVEMEAMEALPVTWGTSSRDEDLENCSHHL → ASVCSCHPRSAGHTCSVGSV
Notes: Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.
Isoform 8 (identifier: Q13261-8)

Also known as: delta2deltaE1E73Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     30-127: Missing.
Notes: Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.
Isoform 9 (identifier: Q13261-9)

Also known as: delta2delta3E1E7'Il-15RA;

The sequence of this isoform differs from the canonical sequence as follows:
     30-127: Missing.
     232-267: QTPPLASVEMEAMEALPVTWGTSSRDEDLENCSHHL → ASVCSCHPRSAGHTCSVGSV
Notes: Isoform 6, isoform 7, isoform 8 and isoform 9 are associated with endoplasmic reticulum, Golgi and cytoplasmic vesicles, but not with the nuclear membrane.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 3030 Potential
Chain31 – 267237Interleukin-15 receptor subunit alpha
PRO_0000011044
Chain31 – ?Soluble interleukin-15 receptor subunit alphaPRO_0000333855

Regions

Topological domain31 – 205175Extracellular Potential
Transmembrane206 – 22823 Potential
Topological domain229 – 26739Cytoplasmic Potential
Domain31 – 9565Sushi

Amino acid modifications

Glycosylation1371N-linked (GlcNAc...) Potential
Disulfide bond33 ↔ 75
Disulfide bond59 ↔ 93

Natural variations

Alternative sequence1 – 3636Missing in isoform 2.
VSP_012622
Alternative sequence30 – 12798Missing in isoform 8 and isoform 9.
VSP_012623
Alternative sequence31 – 9565Missing in isoform 6 and isoform 7.
VSP_012624
Alternative sequence95 – 12834RDPAL…PSGKE → K in isoform 3 and isoform 5.
VSP_012625
Alternative sequence232 – 26736QTPPL…CSHHL → ASVCSCHPRSAGHTCSVGSV in isoform 4, isoform 5, isoform 7 and isoform 9.
VSP_012626
Natural variant1821N → T: dbSNP rs2228059.
VAR_020967

Experimental info

Mutagenesis2271Y → F: Abrogates association with SYK and phosphorylation upon IL-15 stimulation
Sequence conflict2001G → D in AAH74726. Ref.6

Secondary structure

................. 267
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified November 1, 1996. Version 1.
Checksum: A9CFC885189E96BE

FASTA26728,233
        10         20         30         40         50         60 
MAPRRARGCR TLGLPALLLL LLLRPPATRG ITCPPPMSVE HADIWVKSYS LYSRERYICN 

        70         80         90        100        110        120 
SGFKRKAGTS SLTECVLNKA TNVAHWTTPS LKCIRDPALV HQRPAPPSTV TTAGVTPQPE 

       130        140        150        160        170        180 
SLSPSGKEPA ASSPSSNNTA ATTAAIVPGS QLMPSKSPST GTTEISSHES SHGTPSQTTA 

       190        200        210        220        230        240 
KNWELTASAS HQPPGVYPQG HSDTTVAIST STVLLCGLSA VSLLACYLKS RQTPPLASVE 

       250        260 
MEAMEALPVT WGTSSRDEDL ENCSHHL 

« Hide

Isoform 2 [UniParc].

Checksum: 85A770AB71977219
Show »

23124,388
Isoform 3 (delta3E1E7Il-15RA) [UniParc].

Checksum: 9ACAD3E117A8C9AF
Show »

23424,870
Isoform 4 (E1E7'Il-15RA) [UniParc].

Checksum: 7933D9E843EDC69E
Show »

25126,196
Isoform 5 (delta3E1E7'Il-15RA) [UniParc].

Checksum: F64A227CB6AA3FC5
Show »

21822,833
Isoform 6 (delta2E1E7Il-15RA) [UniParc].

Checksum: D4F5DD2EA004C6D2
Show »

20220,904
Isoform 7 (delta2E1E7'Il-15RA) [UniParc].

Checksum: F5B6202C329FB0C8
Show »

18618,866
Isoform 8 (delta2deltaE1E73Il-15RA) [UniParc].

Checksum: 238A6ECC5B7675A1
Show »

16917,641
Isoform 9 (delta2delta3E1E7'Il-15RA) [UniParc].

Checksum: 1224FD25881D2C79
Show »

15315,604

References

« Hide 'large scale' references
[1]"Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes."
Anderson D.M., Kumaki S., Ahdieh M., Bertles J., Tometsko M., Loomis A., Giri J., Copeland N.G., Gilbert D.J., Jenkins N.A., Valentine V., Shapiro D.N., Morris S.W., Park L.S., Cosman D.
J. Biol. Chem. 270:29862-29869(1995) [PubMed: 8530383] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4), FUNCTION, TISSUE SPECIFICITY, VARIANT THR-182.
Tissue: Bone marrow stroma.
[2]"Large-scale concatenation cDNA sequencing."
Yu W., Andersson B., Worley K.C., Muzny D.M., Ding Y., Liu W., Ricafrente J.Y., Wentland M.A., Lennon G., Gibbs R.A.
Genome Res. 7:353-358(1997) [PubMed: 9110174] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Brain.
[3]"Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)."
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.
Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
[4]SeattleSNPs program for genomic applications
Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-182.
[5]"The DNA sequence and comparative analysis of human chromosome 10."
Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. expand/collapse author list , Bird C.P., Ainscough R., Almeida J.P., Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.
Nature 429:375-381(2004) [PubMed: 15164054] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[6]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Tissue: Brain.
[7]"Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression."
Dubois S., Magrangeas F., Lehours P., Raher S., Bernard J., Boisteau O., Leroy S., Minvielle S., Godard A., Jacques Y.
J. Biol. Chem. 274:26978-26984(1999) [PubMed: 10480910] [Abstract]
Cited for: ALTERNATIVE SPLICING (ISOFORMS 1; 3; 4; 5; 6; 7; 8 AND 9), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, GLYCOSYLATION.
[8]"The IL-15R alpha chain signals through association with Syk in human B cells."
Bulanova E., Budagian V., Pohl T., Krause H., Durkop H., Paus R., Bulfone-Paus S.
J. Immunol. 167:6292-6302(2001) [PubMed: 11714793] [Abstract]
Cited for: FUNCTION, INTERACTION WITH SYK, PHOSPHORYLATION BY SYK, MUTAGENESIS OF TYR-227.
[9]"Expression of IL-15 and IL-15 receptor isoforms in select structures of human fetal brain."
Kurowska M., Rudnicka W., Maslinska D., Maslinski W.
Ann. N. Y. Acad. Sci. 966:441-445(2002) [PubMed: 12114302] [Abstract]
Cited for: TISSUE SPECIFICITY.
[10]"Identification of an interleukin-15alpha receptor-binding site on human interleukin-15."
Bernard J., Harb C., Mortier E., Quemener A., Meloen R.H., Vermot-Desroches C., Wijdeness J., van Dijken P., Grotzinger J., Slootstra J.W., Plet A., Jacques Y.
J. Biol. Chem. 279:24313-24322(2004) [PubMed: 15039446] [Abstract]
Cited for: LIGAND-BINDING.
[11]"Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist."
Mortier E., Bernard J., Plet A., Jacques Y.
J. Immunol. 173:1681-1688(2004) [PubMed: 15265897] [Abstract]
Cited for: PROTEOLYTIC PROCESSING, LIGAND-BINDING.
[12]"The structure of the interleukin-15 alpha receptor and its implications for ligand binding."
Lorenzen I., Dingley A.J., Jacques Y., Grotzinger J.
J. Biol. Chem. 281:6642-6647(2006) [PubMed: 16377614] [Abstract]
Cited for: STRUCTURE BY NMR OF 31-96, DISULFIDE BONDS.
+